More like the expected preliminary data readout from the Path BioAnlytics tests of our compounds as forecast in the 16 July 2020 announcement. Given these were effectively tested on an "ex vivo respiratory organoid model", even with very positive results we have a long way to go before producing an accepted treatment.
RCE Price at posting:
$1.48 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)